Clinical Commissioning Policy: Use of cobicistat as a booster in treatment of HIV infection (all ages)

Document first published:: 26 September 2018
Page updated:: 26 September 2018
Topic:: Commissioning, Specialised commissioning
Publication type:: Policy or strategy

This policy document outlines the arrangements for funding of the use of cobicistat as a booster in treatment of HIV infection (all ages).

Document

Clinical Commissioning Policy: Use of cobicistat as a booster in treatment of HIV infection (all ages)

Clinical Commissioning Policy: Use of cobicistat as a booster in treatment of HIV infection (all ages)

PDF
390 KB
19 pages